Biomerica prices 1,393,705-share private placement at $1.6 per share, raising $2.23 million
BMRA•Closing, investors and board rights
Closing occurred Aug. 26, 2026; buyers included B. Riley Principal Capital, directors, executive officers, and other investors.
B. Riley gains a board designation right while its group holds at least 10% of voting power, subject to Nasdaq rules.
Private placement pricing and proceeds
Biomerica priced a private placement of 1,393,705 common shares at $1.6 per share, raising about $2.23 million in gross proceeds.
Resale registration and transfer restrictions
The company said it will file a resale registration statement within 30 days and targets effectiveness within 30 days, or 60 days if SEC review is required.
The shares were sold unregistered under Securities Act exemptions, and insiders face 180-day lockups on certain transfers.
